- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 15/10 - Drugs for genital or sexual disordersContraceptives for impotence
Patent holdings for IPC class A61P 15/10
Total number of patents in this class: 567
10-year publication summary
|
11
|
30
|
40
|
40
|
36
|
51
|
31
|
35
|
26
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17737 |
24 |
| Takeda Pharmaceutical Company Limited | 2713 |
8 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 855 |
8 |
| AstraZeneca AB | 2826 |
7 |
| Pfizer Inc. | 3374 |
7 |
| ASKA Pharmaceutical Co., Ltd. | 103 |
7 |
| Kyowa Hakko Bio Co., Ltd. | 294 |
7 |
| Initiator Pharma A/S | 21 |
6 |
| Topadur Pharma AG | 23 |
6 |
| ATIR Holding S.A. | 17 |
5 |
| Banyu Pharmaceutical Co., Ltd. | 52 |
5 |
| Futura Medical Developments Limited | 30 |
5 |
| Topharman Shanghai Co., Ltd. | 53 |
5 |
| Activ'inside | 82 |
4 |
| Nippon Shinyaku Co., Ltd. | 327 |
4 |
| Shionogi & Co., Ltd. | 829 |
4 |
| Sunshine Lake Pharma Co., Ltd. | 613 |
4 |
| Bristol-myers Squibb Company | 4810 |
3 |
| AstraZeneca UK Limited | 581 |
3 |
| Boehringer Ingelheim International GmbH | 4579 |
3 |
| Other owners | 442 |